BiomX, Inc. Quarterly report [Sections 13 or 15(d)]

Basic and Diluted Loss (Earnings) Per Share - Schedule of Anti-dilutive Financial Instruments (Details) - shares	3 Months Ended		6 Months Ended
	Jun. 30, 2025	Jun. 30, 2024	Jun. 30, 2025	Jun. 30, 2024
Options [Member]
Schedule of Anti-dilutive Financial Instruments [Line Items]
Anti-dilutive shares	3,003,359	507,141	3,003,359	507,141
Warrants [Member]
Schedule of Anti-dilutive Financial Instruments [Line Items]
Anti-dilutive shares	18,233,598	1,825,281	18,233,598	12,646,131
Contingent shares [Member]
Schedule of Anti-dilutive Financial Instruments [Line Items]
Anti-dilutive shares	200,000	200,000	200,000	200,000
Redeemable Convertible Preferred Shares [Member]
Schedule of Anti-dilutive Financial Instruments [Line Items]
Anti-dilutive shares	14,773,500	25,688,700	14,773,500	25,688,700